Form 4: UnitedHealth Group Director Timothy Flynn Reports Stock Transactions

Director Timothy Flynn of UnitedHealth Group reported acquiring shares and dividend equivalents, while also transferring shares from a trust.

Summary

• Timothy Flynn, a director at UnitedHealth Group, reported several transactions involving the company's common stock.
• On December 17, 2024, Flynn acquired 38 shares of common stock as dividend equivalents.
• These dividend equivalents were immediately vested and are subject to the same terms as the underlying deferred stock units.
• Also on December 17, 2024, Flynn acquired 8,719 shares of common stock.
• Additionally, 3,500 shares of common stock were disposed of indirectly through a trust.
• On October 10, 2024, 1,500 shares of common stock were substituted for other assets held in the trust, a transaction exempt from Section 16 rules.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of stock transactions by a company director, which is neither positive nor negative in itself.

Industry Context

This filing is a routine disclosure of stock transactions by a company director, which is a common practice in publicly traded companies. It provides transparency into the trading activities of company insiders.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider trading.
• The transactions reported are typical for directors who receive stock-based compensation and may manage personal holdings through trusts.
• Comparable companies would have similar filings for their directors and officers.

Stakeholder Impact

• The transactions have a minimal impact on shareholders as they are routine and do not indicate a significant change in the director's holdings.

Key Dates

Keywords

UnitedHealth Group, UNH, Timothy Flynn, stock transaction, Form 4, dividend equivalents, insider trading, beneficial ownership, trust